PLASMA-LYTE 56 IN PLASTIC CONTAINER Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Plasma-lyte 56 In Plastic Container, and when can generic versions of Plasma-lyte 56 In Plastic Container launch?
Plasma-lyte 56 In Plastic Container is a drug marketed by Baxter Hlthcare and is included in one NDA.
The generic ingredient in PLASMA-LYTE 56 IN PLASTIC CONTAINER is magnesium acetate tetrahydrate; potassium acetate; sodium chloride. There are one hundred and forty-six drug master file entries for this compound. Additional details are available on the magnesium acetate tetrahydrate; potassium acetate; sodium chloride profile page.
Summary for PLASMA-LYTE 56 IN PLASTIC CONTAINER
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Formulation / Manufacturing: | see details |
DailyMed Link: | PLASMA-LYTE 56 IN PLASTIC CONTAINER at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for PLASMA-LYTE 56 IN PLASTIC CONTAINER
US Patents and Regulatory Information for PLASMA-LYTE 56 IN PLASTIC CONTAINER
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Baxter Hlthcare | PLASMA-LYTE 56 IN PLASTIC CONTAINER | magnesium acetate tetrahydrate; potassium acetate; sodium chloride | INJECTABLE;INJECTION | 019047-001 | Jun 15, 1984 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |